Boston Partners’s Catalyst Pharmaceutical CPRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$42.4M	Buy	1,711,573 +480,201	+39%	+$11.4M	0.04%	277
2025 Q4	$28.5M	Sell	1,231,372 -59,687	-5%	-$1.33M	0.03%	333
2025 Q3	$25.6M	Buy	1,291,059 +8,337	+0.6%	+$171K	0.03%	348
2025 Q2	$27.9M	Buy	1,282,722 +7,397	+0.6%	+$175K	0.03%	315
2025 Q1	$30.6M	Sell	1,275,325 -16,543	-1%	-$373K	0.04%	275
2024 Q4	$27.3M	Buy	1,291,868 +16,601	+1%	+$357K	0.03%	294
2024 Q3	$25.6M	Sell	1,275,267 -131,113	-9%	-$2.43M	0.03%	303
2024 Q2	$22M	Sell	1,406,380 -100,550	-7%	-$1.57M	0.03%	316
2024 Q1	$23.8M	Sell	1,506,930 -34,730	-2%	-$523K	0.03%	304
2023 Q4	$25.6M	Buy	1,541,660 +1,396,930	+965%	+$19.1M	0.03%	300
2023 Q3	$1.69M	Hold	144,730	–	–	﹤0.01%	507
2023 Q2	$1.95M	Hold	144,730	–	–	﹤0.01%	482
2023 Q1	$2.4M	Hold	144,730	–	–	﹤0.01%	450
2022 Q4	$2.69M	Buy	144,730 +3,351	+2%	+$51.6K	﹤0.01%	431
2022 Q3	$1.81M	Buy	141,379 +2,821	+2%	+$33.4K	﹤0.01%	456
2022 Q2	$971K	Buy	138,558 +62,812	+83%	+$461K	﹤0.01%	514
2022 Q1	$628K	Buy	+75,746	New	+$536K	﹤0.01%	603